ROIS

ROIS is a top 3 worldwide injectable CDMO, delivering end-to-end aseptic fill-finish solutions for injectable drugs in vials, prefilled syringes (PFS), cartridges, and AI/Pens, leveraging FDA, EMA, PMDA, ANVISA, MHRA, and KFDA approvals and cutting-edge isolator/RABS technology. We also offer solid-dose tablets and sachets. With high-speed, validated lines and in-house packaging, labeling, serialization, and QA labs, ROIS simplifies global injectable supply chains, compressing timelines and mitigating risk for pharma/biotech partners.

FEATURED ARTICLES

Reflecting On 2025: Innovation & Investment
As capacity expands and capabilities mature, CDMOs with global scale and advanced injectable expertise are becoming critical partners for bringing complex sterile drug products to market.
Scaling For The GLP-1 Revolution: Meeting Global Injectable Demand
To keep pace with surging GLP-1 demand, pharma needs partners that can rapidly scale injectable production while maintaining flexibility, quality, and regulatory rigor.
CDMO Partnerships: Why Speed And Flexibility Matter Now More Than Ever
As demand for GLP-1s and biologics accelerates and timelines compress, it's become more crucial that pharmaceutical companies stay competitive and bring therapies to market faster by partnering with a CDMO.

ROIS

FEATURED ARTICLES

CONTACT INFORMATION

SOLUTIONS